ADPT
Adaptive Biotechnologies Corporation
Halal Rating :
See Details
Last Price
$4.80
Last updated:
Market Cap
$788.32m
7D Change
-14.89%
1 Year Change
-41.39%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 2, 2023
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company is headquartered in Seattle, Washington.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $45.32m | $78.83m | $3.61m | $3.6m | 7.97% | 4.57% |
| March 31, 2023 | $34.12m | $76.16m | $3.02m | $3.53m | 8.86% | 4.64% |
| Dec. 31, 2022 | $51.61m | $77.8m | $2.6m | $3.58m | 5.04% | 4.61% |
Company Impact
Help us evaluate Adaptive Biotechnologies Corporation's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.